How have LNDZF shares performed in 2024?

Evome Medical Technologies' stock was trading at $0.1516 on January 1st, 2024. Since then, LNDZF shares have increased by 38.5% and is now trading at $0.21. View the best growth stocks for 2024 here .

Are investors shorting Evome Medical Technologies?

Evome Medical Technologies saw a drop in short interest in the month of March. As of March 15th, there was short interest totaling 200 shares, a drop of 97.6% from the February 29th total of 8,200 shares. Based on an average daily volume of 4,900 shares, the days-to-cover ratio is currently 0.0 days. View Evome Medical Technologies' Short Interest .

When is Evome Medical Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our LNDZF earnings forecast .

How do I buy shares of Evome Medical Technologies?

Shares of LNDZF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:LNDZF

Evome Medical Technologies (LNDZF) Stock Price, News & Analysis

→ With the “Bitcoin Loophole” you can supercharge the gains by 10x or more (From DTI) (Ad)

Free LNDZF Stock Alerts

$0.21

0.00 (0.00%)

(As of 04/17/2024 ET)

Compare

Today's Range: $0.21
▼
$0.21
50-Day Range: $0.13
▼
$0.21
52-Week Range: $0.02
▼
$0.32

Volume: N/A
Average Volume: 7,738 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials Headlines SEC Filings Short Interest

Get Evome Medical Technologies alerts:

Ad DTI

This company has increased its dividend every year for 54 years

There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.

Click here to get them (for Free).

About Evome Medical Technologies Stock (OTCMKTS:LNDZF)

Evome Medical Technologies Inc., through its subsidiaries, engages in the development, production, and sale of medical devices and products in the United States. The company's medical devices are used for pain management and physical therapy treatments, including cold/hot therapy products, neuromuscular electrical stimulation devices, transcutaneous electrical nerve stimulation devices, and ultrasound treatment devices. It also offers wearable technology and products that are used to enhance physical stability. The company was formerly known as Salona Global Medical Device Corporation and changed its name to Evome Medical Technologies Inc. in January 2024. Evome Medical Technologies Inc. is headquartered in Shirley, New York.

LNDZF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

LNDZF Stock News Headlines

April 12, 2024 | finance.yahoo.com

Evome Strengthens Major Creditor Relationship After the Sale of the Simbex Unit to Riddell, LOI Related to Simbex Acquisition Debt is Cancelled

April 2, 2024 | finance.yahoo.com

Canadian Investment Regulatory Organization Trade Resumption - EVMT

April 18, 2024 | DTI (Ad)

A new way to collect income from stocks

Most people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively…

April 2, 2024 | finance.yahoo.com

Evome Sells Simbex R&D Business Unit to Riddell for $4.83M in Cash; Improves Balance Sheet, Reduces Biodex Acquisition Debt

April 1, 2024 | globenewswire.com

Evome Medical Technologies Punctuates Turn Around Plan with Strong Fourth Quarter Resulting in Positive Annual Adjusted EBITDA for Fiscal Year 2023

February 27, 2024 | globenewswire.com

Evome Medical Engages ICP Securities Inc. for Automated Market Making Services

February 15, 2024 | finance.yahoo.com

Evome Medical Technologies Bolsters Board of Directors with Appointment of Strategic Senior Healthcare Executives Wayne Anderson and Bill Garbarini, Appoints Kenneth Kashkin, MD, as Chairman

February 15, 2024 | globenewswire.com

Evome Medical Technologies Bolsters Board of Directors with Appointment of Strategic Senior Healthcare Executives Wayne Anderson and Bill Garbarini, Appoints Kenneth Kashkin, MD, as Chairman

April 18, 2024 | DTI (Ad)

A new way to collect income from stocks

February 8, 2024 | finance.yahoo.com

Evome Medical Technologies Executes Non-Binding Letter of Intent to Extend Remaining Simbex Acquisition Debt to June 2025; Increases Sales Targets by 7.5% for Biodex Distribution Contracts; Raises Biodex Product Pricing by 2% for 2024

January 31, 2024 | finance.yahoo.com

Evome Medical Technologies Reduces Acquisition Debt, Bolsters Management Team to Support SpaceTeck Knee™ and Reactive Step Trainer 2024 Product Roll-Out

January 18, 2024 | finance.yahoo.com

Salona Global Finalizes Name Change to Evome Medical Technologies to Reflect Turn Around and New Innovation Focus; Restructures Board of Directors

January 11, 2024 | finance.yahoo.com

Salona Global Announces Exclusive Partnership with Recently Launched U.S. Military Veteran (VA) Focused Distribution Company

December 18, 2023 | finance.yahoo.com

Salona Global Announces the Debut of the Biodex Reactive Step Trainer, a Revolutionary Balance Training System to Reduce Falls; Commences AI Enabled Software Component

December 7, 2023 | msn.com

Scottish medical device consortium wins £3.35m to pursue sustainable tech

November 17, 2023 | msn.com

Salona Global announces launch of new device for knee treatment

November 16, 2023 | finance.yahoo.com

Salona Global Announces the Debut of the Biodex SpaceTek Knee™, a Revolutionary Portable Isokinetic Knee Dynamometer Medical Device Developed in NASA Collaboration

November 15, 2023 | finance.yahoo.com

Salona Global Completes Turn Around Plan with Profitable Third Quarter, Posting Record Results with 18.5% Quarterly Organic Revenue Growth and 29% Quarterly Gross Profit Growth; Generates $749,425 in Adjusted EBITDA for the Quarter

November 14, 2023 | finance.yahoo.com

Salona Global Showcases Biodex Products at Medica Trade Fair in Düsseldorf, Germany; Expanding Access to International Markets

October 28, 2023 | msn.com

MedAlliance revolutionising Healthcare through innovation with a global leader Cordis

October 25, 2023 | finance.yahoo.com

Salona Global Announces Large International Order from Polish Distributor Expected to be Delivered in the Current Quarter; Increases Year-over-Year Revenues 157% For the Polish Market

October 23, 2023 | businesswire.com

Global $2.19 Bn Wearable Heart Monitoring Devices Markets, 2017-2022, 2022-2027F, 2032F: Diagnostic And Monitoring Devices, Therapeutic Devices, Electric Pulse, Optical ...

October 19, 2023 | finance.yahoo.com

Salona Global Announces Plans to Change Name to Evome Medical Technologies Inc.; Confirms Positive Adjusted EBITDA and Net Profit for Q3 2023; Appoints New CFO

September 18, 2023 | finance.yahoo.com

Salona Global Announces Expansion of Bank Line

August 29, 2023 | benzinga.com

Medical Device Contract Manufacturing Market Envisioned at $118.9 Billion by 2027

August 17, 2023 | benzinga.com

Global $30+ Bn Medical Digital Imaging System Markets to 2030: Expanding Role in Preventive Healthcare Drives Market Growth

August 15, 2023 | msn.com

Salona Global Medical Device GAAP EPS of -$0.02, revenue of $16.6M

See More Headlines

Receive LNDZF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evome Medical Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/17/2024
Next Earnings (Estimated): 5/14/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Medical Devices
Sub-Industry: N/A
Current Symbol: OTCMKTS:LNDZF
CUSIP: N/A
CIK: 1617765
Web: www.inspirafin.ca
Phone: (800) 760-6826
Fax: N/A
Employees: 144
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Jeffrey Chu
Executive Officer
Mr. Michael Seckler (Age 50)
CEO & Executive Director
Ms. Cherine Pottinger-Harris (Age 43)
Principal Accounting Officer & Interim Chief Financial Officer
Mr. Joseph G. Martinez Esq. (Age 66)
Senior VP of Legal & Compliance, General Counsel and Secretary
Mr. Jethro Rothe-Kushel
Vice President of Capital Markets & Financial Communications

Key Competitors

View All Competitors

LNDZF Stock Analysis - Frequently Asked Questions

How have LNDZF shares performed in 2024?: Evome Medical Technologies' stock was trading at $0.1516 on January 1st, 2024. Since then, LNDZF shares have increased by 38.5% and is now trading at $0.21.
View the best growth stocks for 2024 here.
Are investors shorting Evome Medical Technologies?: Evome Medical Technologies saw a drop in short interest in the month of March. As of March 15th, there was short interest totaling 200 shares, a drop of 97.6% from the February 29th total of 8,200 shares. Based on an average daily volume of 4,900 shares, the days-to-cover ratio is currently 0.0 days.
View Evome Medical Technologies' Short Interest.
When is Evome Medical Technologies' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our LNDZF earnings forecast.
How do I buy shares of Evome Medical Technologies?: Shares of LNDZF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:LNDZF) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial